eStudySite

Oceanside, California 92056

0 studies enrolling now · 14 studies all time

What they study most

Acne Vulgaris, Arthritis, Bacterial Infection, Chronic Hepatitis C, Chronic Plaque Psoriasis, Hepatitis C, Hepatitis C, Chronic, Influenza, Nonalcoholic Steatohepatitis, Osteoarthritis, Psoriasis, Skin Infection

Studies at this site

• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip — Stopped early
• Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis — Stopped early
• A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections — Completed
• Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris — Completed
• Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis — Completed
• Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections — Completed
• Gilead Sustained Virologic Response (SVR) Registry — Completed
• Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza — Completed
• A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed
• Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies — Completed
• Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6 — Completed
• Phase 3 Study of Sofosbuvir and Ribavirin — Completed
• A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed
• Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV — Completed